Division of Nephrology Department of Medicine University of Alabama at Birmingham AL.
Department of Pharmacology School of Medicine Tulane University New Orleans LA.
J Am Heart Assoc. 2020 May 18;9(10):e015110. doi: 10.1161/JAHA.119.015110. Epub 2020 May 10.
Background The novel estrogen receptor, G-protein-coupled estrogen receptor (GPER), is responsible for rapid estrogen signaling. GPER activation elicits cardiovascular and nephroprotective effects against salt-induced complications, yet there is no direct evidence for GPER control of renal Na handling. We hypothesized that GPER activation in the renal medulla facilitates Na excretion. Methods and Results Herein, we show that infusion of the GPER agonist, G1, to the renal medulla increased Na excretion in female Sprague Dawley rats, but not male rats. We found that GPER mRNA expression and protein abundance were markedly higher in outer medullary tissues from females relative to males. Blockade of GPER in the renal medulla attenuated Na excretion in females. Given that medullary endothelin 1 is a well-established natriuretic factor that is regulated by sex and sex steroids, we hypothesized that GPER activation promotes natriuresis via an endothelin 1-dependent pathway. To test this mechanism, we determined the effect of medullary infusion of G1 after blockade of endothelin receptors. Dual endothelin receptor subtype A and endothelin receptor subtype B antagonism attenuated G1-induced natriuresis in females. Unlike males, female mice with genetic deletion of GPER had reduced endothelin 1, endothelin receptor subtype A, and endothelin receptor subtype B mRNA expression compared with wild-type controls. More important, we found that systemic GPER activation ameliorates the increase in mean arterial pressure induced by ovariectomy. Conclusions Our data uncover a novel role for renal medullary GPER in promoting Na excretion via an endothelin 1-dependent pathway in female rats, but not in males. These results highlight GPER as a potential therapeutic target for salt-sensitive hypertension in postmenopausal women.
新型雌激素受体 G 蛋白偶联雌激素受体(GPER)负责快速的雌激素信号转导。GPER 激活可发挥心血管和肾脏保护作用,预防盐诱导的并发症,但尚无直接证据表明 GPER 控制肾脏钠处理。我们假设,肾脏髓质中的 GPER 激活有助于钠排泄。
本研究显示,将 GPER 激动剂 G1 输注到肾脏髓质可增加雌性 Sprague Dawley 大鼠的钠排泄,但对雄性大鼠没有作用。我们发现,雌性大鼠的外髓组织中 GPER mRNA 表达和蛋白丰度明显高于雄性大鼠。肾脏髓质中 GPER 阻断可减弱雌性大鼠的钠排泄。鉴于髓质内皮素 1 是一种已确立的具有性别和性激素调节作用的利钠因子,我们假设 GPER 激活通过内皮素 1 依赖性途径促进利钠作用。为了验证该机制,我们在阻断内皮素受体后测定了肾脏髓质中 G1 输注的作用。双重内皮素受体 A 和内皮素受体 B 拮抗剂可减弱 G1 诱导的雌性大鼠的利钠作用。与雄性大鼠不同,与野生型对照相比,GPER 基因敲除的雌性小鼠的内皮素 1、内皮素受体 A 和内皮素受体 B mRNA 表达减少。更重要的是,我们发现全身 GPER 激活可改善去卵巢引起的平均动脉压升高。
我们的数据揭示了肾脏髓质 GPER 的一个新作用,即通过内皮素 1 依赖性途径促进雌性大鼠而不是雄性大鼠的钠排泄。这些结果强调了 GPER 作为绝经后女性盐敏感性高血压的潜在治疗靶点。